Evidence map›Paper›PMID 40265142›Full record

ArticleCase reports in pulmonology2025

A Subtle Presentation of Pharyngitis and Pneumonia: Lemierre Syndrome.

Federico Bellini, Valentino Allocca, Laura Aspidistria, Marco Farinatti, Ippolito Guzzinati, Marta Maria Daniele, Serena Casanova, Francesca Gasparini, Mara Nalin, Sara Saturni and 1 more

Abstract readCase Reports
In one paragraph

Article in Case reports in pulmonology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Federico BelliniRespiratory Semi-Intensive Care Unit, Department of Specialistic Medicine, Ulss 5 Polesana, Rovigo, Italy.
Valentino AlloccaRespiratory Semi-Intensive Care Unit, Department of Specialistic Medicine, Ulss 5 Polesana, Rovigo, Italy.ORCID https://orcid.org/0000-0002-3288-2808
Laura AspidistriaRespiratory Semi-Intensive Care Unit, Department of Specialistic Medicine, Ulss 5 Polesana, Rovigo, Italy.
Marco FarinattiRespiratory Semi-Intensive Care Unit, Department of Specialistic Medicine, Ulss 5 Polesana, Rovigo, Italy.
Ippolito GuzzinatiRespiratory Semi-Intensive Care Unit, Department of Specialistic Medicine, Ulss 5 Polesana, Rovigo, Italy.
Marta Maria DanieleRespiratory Semi-Intensive Care Unit, Department of Specialistic Medicine, Ulss 5 Polesana, Rovigo, Italy.
Serena CasanovaRespiratory Semi-Intensive Care Unit, Department of Specialistic Medicine, Ulss 5 Polesana, Rovigo, Italy.
Francesca GaspariniRespiratory Semi-Intensive Care Unit, Department of Specialistic Medicine, Ulss 5 Polesana, Rovigo, Italy.
Mara NalinRespiratory Semi-Intensive Care Unit, Department of Specialistic Medicine, Ulss 5 Polesana, Rovigo, Italy.
Sara SaturniRespiratory Semi-Intensive Care Unit, Department of Specialistic Medicine, Ulss 5 Polesana, Rovigo, Italy.
Gian Luca CasoniRespiratory Semi-Intensive Care Unit, Department of Specialistic Medicine, Ulss 5 Polesana, Rovigo, Italy.ORCID https://orcid.org/0000-0002-7218-7914

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lemierre syndrome (LS) is a rare condition with an estimated incidence of 1-10/1,000,000 per year defined as a complication of an oral and nasopharyngeal infection with secondary septicemia leading to septic emboli and internal jugular vein thrombosis. This syndrome was first described by Andre' Lemierre in 1936, before the development of antibiotics. In the preantibiotic era, it was a common condition and it was often characterized by a fatal course within 7-15 days with a mortality rate that could reach up to 80% of cases. After the development of antibiotic therapies, the incidence of LS rapidly declined, and nowadays, it is also known as "the forgotten disease," but the mortality risk remains high (5%) especially in case of diagnostic delay and inappropriate therapies. We presented a case of a 23-year-old who was referred to our hospital for worsening dyspnea associated with high fever following a pharyngitis in order to raise awareness about this severe rare disease. Long-term outcomes are usually good if proper treatment is started with no delay. The mainstays of treatment for the pulmonary and vascular aspects are antibiotic treatment with or without anticoagulation and chest-tube drainage.

Identifiers

PMID40265142
PMCPMC12014257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.